Characterization of Adverse Cutaneous Effects in the Setting of Enfortumab Vedotin for Metastatic Urothelial Carcinoma - a Retrospective Review.

Malik, Rhea; Xiang, David H; Riew, Grant J; Sanchez-Melendez, Stephanie; Afvari, Shawn; LeBoeuf, Nicole R; Nambudiri, Vinod E.

Afiliação

Malik R; Harvard Medical School; Brigham and Women's Hospital, Department of Dermatology.
Xiang DH; Harvard Medical School; Brigham and Women's Hospital, Department of Dermatology.
Riew GJ; Harvard Medical School; Brigham and Women's Hospital, Department of Dermatology.
Sanchez-Melendez S; Ponce Health Sciences University, School of Medicine; Brigham and Women's Hospital, Department of Dermatology.
Afvari S; New York Medical College; Brigham and Women's Hospital, Department of Dermatology.
LeBoeuf NR; Brigham and Women's Hospital, Department of Dermatology; Dana Farber Cancer Institute, Department of Cutaneous Oncology.
Nambudiri VE; Brigham and Women's Hospital, Department of Dermatology; Dana Farber Cancer Institute, Department of Cutaneous Oncology. Electronic address: vnambudiri@bwh.harvard.edu.

J Am Acad Dermatol ; 2024 Jun 21.

Article em En | MEDLINE | ID: mdl-38909660